More EMvision Medical Devices Ltd. news
EMvision Medical Devices Ltd.ASX: EMV

$8.8m In Non-Dilutive Funding To Be Received This Quarter

Nov 30, 2022 at 9:39 PM EST · Issued by EMvision Medical Devices Ltd.

Filed with ASX · Nov 30, 2022 at 9:39 PM EST · 2 pages · English

On 6ix: 6ix.com/news/dollar8.8m-in-non-dilutive-funding-to-be-received-this-quarter

EMvision Medical Devices Ltd. on 6ix

Story so far

  • EMVision Awarded $5m Non-Dilutive Funding via MMI GrantMay 18, 2022
  • EMVision Receives $3.4m Non-Dilutive Funding this QuarterDec 8, 2021

Earlier from EMvision Medical Devices

  • EMVision Commences Clinical TrialNov 29, 2022
  • AGM Chairman Address and PresentationNov 15, 2022
  • Portable Brain Scanner Delivered to First Clinical SiteNov 13, 2022
  • EMVision Backed By NSW Medical Devices Fund With $2.5m GrantNov 10, 2022
  • $5m Modern Manufacturing Initiative Funding Agreement SignedOct 24, 2022

Later from EMvision Medical Devices

  • Trial Progressing on Target and ASA Milestone AchievedJan 24, 2023
  • Clinical Trial Stage 1 Enrolment CompletedFeb 20, 2023
  • CEO Half-Year UpdateFeb 27, 2023
  • Product Development Milestones & Grant Funding AchievedApr 16, 2023
  • Stage 2 of Clinical Trial ActivatedMay 28, 2023
All EMvision Medical Devices news releases↗

Follow EMvision Medical Devices into a list and get an email when it puts out news.

Follow EMvision Medical Devices
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer